Generic Drugs Should Be Cheap, but Insurers Are Charging Thousands of Dollars for Them
News
Miller-Meeks, Ross, Carter, Peters Introduce the Share the Savings with Seniors Act
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
Mid-Year Updates on PBM Legislation
Upcoming DIR Fee Changes Still Causing Concern for Pharmacists
Fitting the bill: Pharmacy legislation tackles important issues
Health Care’s Intertwined Colossus
How the prescription drug supply chain is killing local pharmacies
Senate Finance Committee votes to impose drug pricing standards on PBMs
Nearly 2,000 Organizations Urge Congress to Pass PBM Reform
Financing the healthcare of tomorrow playlist: Tracks for consumers and policymakers
How To Lower Insulin Prices? Focus on the Middleman.
Sen. Bill Cassidy: Smart, practical ways to lower drug prices
Sen. Grassley calls on GOP leaders to rally support for PBM reforms
CAPITO, COLLEAGUES INTRODUCE BILL TO LOWER DRUG COSTS, HOLD MASSIVE PBM CORPORATIONS ACCOUNTABLE
Drug middlemen catch flak at another congressional hearing
To Reign in Healthcare Costs, Congress Needs to Keep the Heat on PBMs
Titans for PBM Reform: Loretta Boesing & Antonio Ciaccia | PBM Reform
Marshall, Menendez, Blackburn, Wyden, Crapo, & Tester Introduce Bipartisan Legislation to Reform PBM
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
Even Mark Cuban Can’t Fix This Broken Drug System
State Insurance Commissioners Seek Meeting With FTC On PBMs
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
US Officials Probe a New Layer in Opaque Drug Pricing, Supply System